Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP

Molecular and Cellular Endocrinology

Volumn 335, Issue 2, 2011, Pages 148-157

  Goldhar, Anita S ^a   Duan, Renqin ^a   Ginsburg, Erika ^a   Vonderhaar, Barbara K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Mammary; Progesterone; Prolactin; Prolactin receptor promoter

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; MESSENGER RNA; PROGESTERONE; PROLACTIN RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; BINDING SITE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER CELL CULTURE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; EPITHELIUM CELL; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HORMONE ACTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE RESPONSIVE ELEMENT; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; CELL LINE, TUMOR; GENES, REPORTER; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; MICE; PROGESTERONE; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTORS, PROGESTERONE; RECEPTORS, PROLACTIN; RECOMBINANT PROTEINS; RESPONSE ELEMENTS; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 79951725581     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2011.01.004     Document Type: Article

References (51)

1. Aupperlee M.D., Smith K.T., Kariagina A., Haslam S.Z. Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development. Endocrinology 2005, 146:3577-3588.
2. Bamberger A.M., Bamberger C.M., Gellersen B., Schulte H.M. Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:6169-6174.
3. Bamberger A.M., Milde-Langosch K., Schulte H.M., Loning T. Progesterone receptor isoforms, PR-B and PR-A, in breast cancer: correlations with clinicopathologic tumor parameters and expression of AP-1 factors. Horm. Res. 2000, 54:32-37.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
5. Clevenger C.V., Furth P.A., Hankinson S.E., Schuler L.A. The role of prolactin in mammary carcinoma. Endocr. Rev. 2003, 24:1-27.
6. Davis J.A., Linzer D.I.H. Expression of multiple forms of the prolactin receptor in mouse liver. Mol. Endocrinol. 1989, 3:674-680.
7. Dong J., Tsai-Morris C.H., Dufau M.L. A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor. J. Biol. Chem. 2006, 281:18825-18836.
8. Duan R., Ginsburg E., Vonderhaar B.K. Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells. Mol. Cell Endocrinol. 2008, 281:9-18.
9. Faivre E.J., Daniel A.R., Hillard C.J., Lange C.A. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors. Mol. Endocrinol. 2008, 22:823-837.
10. Faivre E.J., Lange C.A. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Mol. Cell Biol. 2007, 27:466-480.
11. Goldhar A.S., Vonderhaar B.K., Trott J.F., Hovey R.C. Prolactin-induced expression of vascular endothelial growth factor via Egr-1. Mol. Cell Endocrinol. 2005, 232:9-19.
12. Gonzalez L., Zambrano A., Lazaro-Trueba I., Lopez E., Gonzalez J.J., Martin-Perez J., Aranda A. Activation of the unliganded estrogen receptor by prolactin in breast cancer cells. Oncogene 2009, 28:1298-1308.
13. Graham J.D., Yeates C., Balleine R.L., Harvey S.S., Milliken J.S., Bilous A.M., Clarke C.L. Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res. 1995, 55:5063-5068.
14. Grimm S.L., Seagroves T.N., Kabotyanski E.B., Hovey R.C., Vonderhaar B.K., Lydon J.P., Miyoshi K., Hennighausen L., Ormandy C.J., Lee A.V., Stull M.A., Wood T.L., Rosen J.M. Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Mol. Endocrinol. 2002, 16:2675-2691.
15. Hagan C.R., Faivre E.J., Lange C.A. Scaffolding actions of membrane-associated progesterone receptors. Steroids 2009, 74:568-572.
16. Hovey R.C., Trott J.F., Ginsburg E., Goldhar A., Sasaki M.M., Fountain S.J., Sundararajan K., Vonderhaar B.K. Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev. Dyn. 2001, 222:192-205.
17. Hovey R.C., Trott J.F., Vonderhaar B.K. Establishing a framework for the functional mammary gland: from endocrinology to morphology. J. Mammary Gland Biol. Neoplasia 2002, 7:17-38.
18. Hu Z., Zhuang L., Dufau M.L. Multiple and tissue-specific promoter control of gonadal and non-gonadal prolactin receptor gene expression. J. Biol. Chem. 1996, 271:10242-10246.
19. Hu Z.Z., Meng J., Dufau M.L. Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11. J. Biol. Chem. 2001, 276:41086-41094.
20. Hu Z.Z., Zhuang L., Dufau M.L. Prolactin receptor gene diversity: structure and regulation. Trends Endocrinol. Metab. 1998, 9:94-102.
21. Hu Z.Z., Zhuang L., Meng J., Dufau M.L. Transcriptional regulation of the generic promoter III of the rat prolactin receptor gene by C/EBPbeta and Sp1. J. Biol. Chem. 1998, 273:26225-26235.
22. Hu Z.Z., Zhuang L., Meng J., Leondires M., Dufau M.L. The human prolactin receptor gene structure and alternative promoter utilization: the generic promoter hPIII and a novel human promoter hP(N). J. Clin. Endocrinol. Metab. 1999, 84:1153-1156.
23. Jacobsen B.M., Richer J.K., Schittone S.A., Horwitz K.B. New human breast cancer cells to study progesterone receptor isoform ratio effects and ligand-independent gene regulation. J. Biol. Chem. 2002, 277:27793-27800.
24. Kariagina A., Aupperlee M.D., Haslam S.Z. Progesterone receptor isoform functions in normal breast development and breast cancer. Crit. Rev. Eukaryot. Gene Expr. 2008, 18:11-33.
25. Koseki Y., Cole D., Matsuzawa A., Costlow M.E. Prolactin regulation of estrogen and progesterone receptors in normal and neoplastic mouse mammary tissue. Jpn. J. Cancer Res. 1987, 78:1105-1111.
26. Koslowski M., Tureci O., Biesterfeld S., Seitz G., Huber C., Sahin U. Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT/enhancer-binding protein beta (C/EBPbeta) isoform 2. J. Biol. Chem. 2009, 284:28607-28615.
27. Lange C.A., Sartorius C.A., Abdel-Hafiz H., Spillman M.A., Horwitz K.B., Jacobsen B.M. Progesterone receptor action: translating studies in breast cancer models to clinical insights. Adv. Exp. Med. Biol. 2008, 630:94-111.
28. Leroy-Martin B., Peyrat J.P. Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D). Anticancer Res. 1989, 9:631-636.
29. Lopez-Rodriguez C., Botella L., Corbi A.L. CCAAT-enhancer-binding proteins (C/EBP) regulate the tissue specific activity of the CD11c integrin gene promoter through functional interactions with Sp1 proteins. J. Biol. Chem. 1997, 272:29120-29126.
30. McGowan E.M., Russell A.J., Boonyaratanakornkit V., Saunders D.N., Lehrbach G.M., Sergio C.M., Musgrove E.A., Edwards D.P., Sutherland R.L. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor. Cancer Res. 2007, 67:8942-8951.
31. Moldrup A., Ormandy C., Nagano M., Murthy K., Banville D., Tronche F., Kelly P.A. Differential promoter usage in prolactin receptor gene expression: hepatocyte nuclear factor 4 binds to and activates the promoter preferentially active in the liver. Mol. Endocrinol. 1996, 10:661-671.
32. Morabito J.E., Trott J.F., Korz D.M., Fairfield H.E., Buck S.H., Hovey R.C. A 5' distal palindrome within the mouse mammary tumor virus-long terminal repeat recruits a mammary gland-specific complex and is required for a synergistic response to progesterone plus prolactin. J. Mol. Endocrinol. 2008, 41:75-90.
33. Mote P.A., Bartow S., Tran N., Clarke C.L. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res. Treat. 2002, 72:163-172.
34. Murphy L.J., Murphy L.C., Stead B., Sutherland R.L., Lazarus L. Modulation of lactogenic receptors by progestins in cultured human breast cancer cells. J. Clin. Endocrinol. Metab. 1986, 62:280-287.
35. Ormandy C.J., Binart N., Helloco C., Kelly P.A. Mouse prolactin receptor gene: genomic organization reveals alternative promoter usage and generation of isoforms via alternative 3'-exon splicing. DNA Cell Biol. 1998, 17:761-770.
36. Ormandy C.J., Hall R.E., Manning D.L., Robertson J.F.R., Blamey R.W., Kelly P.A., Nicholson R.I., Sutherland R.L. Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. J. Clin. Endocrinol. Metab. 1997, 82:3692-3699.
37. Owen G.I., Richer J.K., Tung L., Takimoto G., Horwitz K.B. Progesterone regulates transcription of the p21(WAF1) cyclin- dependent kinase inhibitor gene through Sp1 and CBP/p300. J. Biol. Chem. 1998, 273:10696-10701.
38. Pinkas J., Leder P. MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition. Cancer Res. 2002, 62:4781-4790.
39. Reichmann E., Schwarz H., Deiner E.M., Leitner I., Eilers M., Berger J., Busslinger M., Beug H. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 1992, 71:1103-1116.
40. Sakai S., Bowman P.D., Yang J., McCormick K., Nandi S. Glucocorticoid regulation of prolactin receptors on mammary cells in culture. Endocrinology 1979, 104:1447-1449.
41. Satoh K., Hovey R.C., Malewski T., Warri A., Goldhar A.S., Ginsburg E., Saito K., Lydon J.P., Vonderhaar B.K. Progesterone enhances branching morphogenesis in the mouse mammary gland by increased expression of Msx2. Oncogene 2007, 26:7526-7534.
42. Scarpin K.M., Graham J.D., Mote P.A., Clarke C.L. Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression. Nucl. Recept. Signal. 2009, 7:e009.
43. Seagroves T.N., Kmacik S., Raught B., Gay J., Burgess-Beusse B., Darlington G.J., Rosen J.M. C/EPBβ, but not C/EPBα, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev. 1998, 12:1917-1928.
44. Seagroves T.N., Lydon J.P., Hovey R.C., Vonderhaar B.K., Rosen J.M. C/EBPβ (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol. Endocrinol. 2000, 14:359-368.
45. Shyamala G., Yang X., Cardiff R.D., Dale E. Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3044-3049.
46. Tang Q.Q., Lane M.D. Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation. Genes Dev. 1999, 13:2231-2241.
47. Trott J.F., Hovey R.C., Koduri S., Vonderhaar B.K. Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein. J. Mol. Endocrinol. 2003, 30:31-47.
48. Tseng L., Zhu H.H. Progestin, estrogen, and insulin-like growth factor-I stimulate the prolactin receptor mRNA in human endometrial stromal cells. J. Soc. Gynecol. Investig. 1998, 5:149-155.
49. Vonderhaar B.K., Bhattacharya A., Alhadi T., Liscia D.S., Andrew E.M., Young J.K., Ginsburg E., Bhattacharjee M., Horn T.M. Isolation, characterization and regulation of the prolactin receptor. J. Dairy Sci. 1985, 68:466-488.
50. Wu F., Ivanov I., Xu R., Safe S. Role of SP transcription factors in hormone-dependent modulation of genes in MCF-7 breast cancer cells: microarray and RNA interference studies. J. Mol. Endocrinol. 2009, 42:19-33.
51. Wyszomierski S.L., Rosen J.M. Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer-binding protein-beta) on beta-casein gene transcription are mediated by the glucocorticoid receptor. Mol. Endocrinol. 2001, 15:228-240.